4-Methyl-2-(trifluoromethyl)-1,3-thiazole-5-carboxylic acid, 95%, 1g

3-METHOXY-9H-XANTHEN-9-ONE, 90.0%, 2g

Methyl 1-(tert-Butoxycarbonyl)-2-piperidinecarboxylate>98.0%(GC)5g

Ácido levulínico, mínimo 98 %, para síntesis, 50 g, envase de vidrio

2-Methylthiazole-4,5-dicarboxylic acid diethylester, 96.0%, 1g

1-((1S,3R,4R,7S)-7-Hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl)pyrimidine-2,4(1H,3H)-dione, 99.49%, 10mg

3-Indoleacetic Acid>98.0%(T)25g

3-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]propanoic acid, 95.0%, 1g

3-Bromo-2-chloro-5-fluorobenzoic acid, 98%, 100g

Vinyl terminated polydimethylsiloxane cSt 100,000, 100g

FMOC-NLE-OH, 98.0%, 25g

(2E)-1-(4-methylphenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

1-(4-Cyanobenzyl)piperazine, 97.0%, 5g